Transapical Transcatheter Treatment of a Stenosed Aortic Valve Bioprosthesis Using the Edwards SAPIEN Transcatheter Heart Valve

ArticleinThe Annals of thoracic surgery 87(6):1943-6 · July 2009with9 Reads
Impact Factor: 3.85 · DOI: 10.1016/j.athoracsur.2008.11.034 · Source: PubMed


    Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve ( Edwards Lifesciences, Irvine, CA). (Ann Thorac Surg 2009; 87: 1943-6) (C) 2009 by The Society of Thoracic Surgeons